Advanced colorectal cancer and malignant tumors metastasize other organs, which seriously threaten human health. Such patients have a low five-year survival rate and poor quality of life. Therefore, it is necessary to study such patients. There is still a long way to go for doctors. Our study uses retrospective research methods to statistically analyze the metastasis of colorectal cancer and other organs and tissues metastasis of colorectal malignant tumors. Let's pay full attention to such patients. Because the treatment recommended by many clinicians in the later stage is different. Some doctors recommend active treatment. Some doctors recommend giving up treatment. Therefore, this study aims to make doctors pay attention to the treatment and treatment process of advanced colorectal cancer and colorectal malignant tumors metastasis of other organs in the later stage, so as to improve the survival rate of patients and improve the quality of life of patients. Research background: At present, colorectal cancer or colorectal malignant tumors seriously endanger human health around the world. The main reason is our insufficient understanding of colorectal cancer. We don't attach importance to health education. We have insufficient preventive measures for intestinal cancer and the promotion of risk factors, and the inadequacy of early screening for intestinal cancer, so that some patients are late tumors when colorectal cancer is found. At the same time, patients with such tumors are prone to the invasion of peripheral tissues or the transfer of tumors to surrounding tissues and organs. The survival rate of patients has been greatly reduced. Objective: To improve the 5-year survival rate of patients with advanced colorectal cancer or malignant colorectal tumor and improve their quality of life. Our research on this kind of patients is meaningful. Research method: We use retrospective research. In CNKI and PubMed public database, the number of studies and cases on the transfer of colorectal cancer or colorectal malignant tumors to other organs from 2020 to 2023 were statistically retrieved, and finally analyzed. Organs include: brain, lung, liver, pancreas, kidney, uterus, ovaries and bones. Included criteria: colorectal cancer or colorectal malignant tumors, brain metastasis, lung metastasis, liver metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis, bone metastasis. Results: The most common metastasis of colorectal cancer in this study is the liver (47.2%), bone (34.9%), lung (7.5%), ovarian and vagina (6.1%), brain (4.3%). Pancreas, kidneys and uterus are relatively rare, but there are still clinical reports.
| Published in | International Journal of Clinical Oncology and Cancer Research (Volume 8, Issue 1) |
| DOI | 10.11648/j.ijcocr.20230801.13 |
| Page(s) | 11-19 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2023. Published by Science Publishing Group |
Stage IV Colorectal Cancer, Malignant Colorectal Tumor, Metastasis, Organs, Standardized Treatment Process, Advanced Tumor
| [1] | Zhang Zhongtao, Yang Yingchi, etc. Strategies for Diagnosis and Treatment of Colon Cancer Zhang Zhongtao 2020 [M]. Beijing: Science and Technology Literature Publishing House, 2020. 7: 1-13. |
| [2] | Emal, A.; Bray, F.; Center, M. M.; Ferlay, J. Forman, D. Global Cancer Statistics. CA: Cancer J. Clin 2011, 61, 69–90. |
| [3] | Kruser, T. J.; Chao, S. T.; Elson, P.; Barnett, G. H.; Vogelbaum, M. A.; Angelov, L.; Weil, R. J.; Pelley, R.; Suh, J. H. Multidisciplinary management of colorectal brain metastases—A retrospective study. Cancer 2008, 113, 158–165. |
| [4] | Rahmathulla, G.; Toms, S. A.; Weil, R. J. The molecular biology of brain metastasis. J. Oncol. 2012, 2012. |
| [5] | Cohen, S. J.; Wang, H.; Rogatko, A.; Meropol, N. J.; Sundermeyer, M. L. Changing Patterns of Bone and Brain Metastases in Patients with Colorectal Cancer. Clin. Colorectal Cancer 2005, 5, 108–113. |
| [6] | Mongan, J. P.; Fadul, C. E.; Cole, B. F.; Zaki, B. I.; Suriawinata, A. A.; Ripple, G. H.; Tosteson, T. D.; Pipas, J. M. Brain metastases from colorectal cancer: Risk factors, incidence, and the possible role of chemokines. Clin. Colorectal Cancer 2009, 8, 100–105. |
| [7] | Jiang, X. -B.; Yang, Q. -Y.; Sai, K.; Zhang, X. -H.; Chen, Z. -P.; Mou, Y. -G. Brain metastases from colorectal carcinoma: A description of 60 cases in a single Chinese cancer center. Tumor Biol 2011, 32, 1249–1256. |
| [8] | Jung, M.; Ahn, J. B.; Chang, J. H.; Suh, C. O.; Hong, S.; Roh, J. K.; Shin, S. J.; Rha, S. Y. Brain metastases from colorectal carcinoma: Prognostic factors and outcome. J. Neuro-Oncol 2011, 101, 49–55. |
| [9] | Jiang, J, Wu, L, Yuan, F, et al. Characterization of the immune microenvironment in brain metastases from different solid tumors. Cancer Med. 2020; 9: 2299– 2308. |
| [10] | Bleckmann, A., Kirchner, B., Nietert, M. et al. Impact of pre-OP independence in patients with limited brain metastases on long-term survival. BMC Cancer 20, 973 (2020). |
| [11] | Omofoye Oluwaseun A., Binello Emanuela. Intraventricular metastases from rectal carcinoma: case report and literature review [J]. The Journal of Biomedical Research, 2020, 34 (4): 318-322. |
| [12] | Wang Yanjun, Wang Qingbing, Zhang Yong, Niu Zhiqiang. Effect of paroxetine on the mental state and cognitive function of patients after brain metastasis of colorectal cancer [J]. International Journal of Psychiatry, 2021, 48 (02): 320-322+329. |
| [13] | Pan Mianshun, Wu Junlan, Wang Peng, Li Yong, Shao Xianjun, Yue Qian, Zhang Guoyu, Zhuge Fenghua, Zhang Feifei, Shen Meihua. Clinical characteristics of brain metastasis of colorectal cancer and analysis of efficacy and prognostic factors of stereotactic radiotherapy [J]. Journal of Stereotactic and Functional Neurosurgery, 2022, 35 (01): 18-23. |
| [14] | Li Zhanwen, Dong Xiaobo, Song Guangrong, Cai Xu, Liu Huimin. 1 case of colon cancer with skull metastasis as the first symptom and literature review [J]. Modern Oncology, 2022, 30 (12): 2260-2262. |
| [15] | Li Li, Ke Yani, Xie Jiebin, Pang Yueshan. Based on the SEER database, a survival prediction model for patients with brain metastasis of primary colorectal cancer is constructed [J]. Western Medicine, 2022, 34 (09): 1361-1365. |
| [16] | SALAH S, WATANABE K, WELTER S PARK JS, PARK JW et al. Colorectal cancer pulmonary oligometastases: pooled analysis and construction of a clinical lung metastasectomy prognostic model. Ann Oncol. 2012; 23: 2649–2655. |
| [17] | Samsami M, Zamani H, Zandpazandi S, Tajik M. Breast and Axillary Metastasis with Colon Cancer Primary Origin. Int J Cancer Manag. 13 (10): e101641. |
| [18] | Murakami et al. surg case rep (2020) 6: 231 https://doi. org/10. 1186/s40792-020-01012-7. |
| [19] | Palmirotta R, Lovero D, D’Oronzo S, Todisco A, Internò V, Mele F, Stucci LS, Silvestris F (2020). Pulmonary enteric adenocarcinoma: an overview. Expert Reviews in Molecular Medicine 22, e1, 1–9. https:// doi. org/10. 1017/erm. 2020. 2. |
| [20] | Wang Yusheng, Zhao Jian, Yang Rong, Ren Jiwei, Zhang Ninggang, Zhang Xuting. Regofinil treated a case of rapid liver and lung metastasis of rectal cancer after second-line chemotherapy [J]. Electronic Journal of Liver Cancer, 2020, 7 (04): 54-58. |
| [21] | Mei Yong, Zhou Zhilin, Zhou Hongmei, Wei Bai. CT diagnosis and risk factor analysis of lung metastasis in elderly colorectal cancer [J]. Chinese medicine, 2020, 15 (12): 1909-1912. |
| [22] | Jia Zhihong, Hu Zhaobing, Wu Yinghong, Wang Renjie, Zhu Qiying. Circulating tumor cells predict lung metastasis in colorectal cancer in 1 case [J]. Journal of Clinical Digestive Diseases, 2020, 32 (05): 332-333. |
| [23] | Li Daojuan, Li Qian, He Yutong. Epidemiological trends of colorectal cancer [J]. Tumor prevention and treatment research, 2015, 42 (3): 305-310. |
| [24] | T. Hasegawa, H. Takaki, H. Kodama, T. Yamanaka, A. Nakatsuka, Y. Sato, Wu Bingjie. 3-year survival rate of radiofrequency ablation for surgically removable colorectal cancer lung metastases: a prospective multi-center study [J]. International Journal of Medical Radiology, 2020, 43 (03): 361. |
| [25] | Wen Zhengqi, Xu Ning, Huang Jian, etc. 1 case of dual cancer of colon + pancreas MDT diagnosis and treatment report [J]. Colorectal anal surgery, 2020, 26 (02): 225-229. |
| [26] | Deng Zijian, Zhang Ke, Yi Bo, Liu Peng, Yan Jin. Survival analysis of lung metastasis and simultaneous liver metastasis in colorectal cancer [J]. Chinese Journal of Oncology, 2020, 12 (02): 130-134. |
| [27] | Wang Shihui, Wang Jie, Pan Hong, Zhong Weisi, Tian Jiandong, Chen Yanzhi, Zhao Yuxia. Apatinib was used to survive for 20. 5 months without progress in lung metastasis in colon cancer and reviewed the literature [J]. Modern Oncology, 2020, 28 (07): 1190-1193. |
| [28] | Li Haiyan. Clinical value of 18F-FDG PET/CT in the differential diagnosis of pulmonary metastasis of pulmonary adenocarcinoma and colorectal cancer [D]. Huazhong University of Science and Technology, 2020. DOI: 10.27157/d.cnki.ghzku.2020.000412. |
| [29] | Li Yuan, Lin Junzhong, Pan Zhizhong. Multidisciplinary comprehensive treatment decision for a patient with suspected lung metastasis with colon cancer [J]. Colorectal anal surgery, 2020, 26 (01): 102-104. |
| [30] | Li Chunxiang, Liu Hengchang, Zhao Zhixun, Guan Xu, Jiang Zheng. A prognostic evaluation model based on 299 patients with heterogeneous lung metastasis in colorectal cancer [J]. Chinese Journal of Colorectal Diseases, 2020, 9 (01): 13-18. |
| [31] | Li Yang. CT-guided percutaneous microwave ablation for the prognosis of lung metastasis in colorectal cancer [J]. Clinical Medical Research and Practice, 2020, 5 (04): 9-10. |
| [32] | Guidelines for the Diagnosis and Comprehensive Treatment of Liver Metastasis of Colorectal Cancer in China (2023) [J]. Chinese clinical medicine, 2023, 30 (01): 166-198. |
| [33] | Bray F et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68 (6): 394–424. |
| [34] | Manfredi S et al (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244 (2): 254–259. |
| [35] | Voß, H., Wurlitzer, M., Smit, D. J. et al. Differential regulation of extracellular matrix proteins in three recurrent liver metastases of a single patient with colorectal cancer. Clin Exp Metastasis 37, 649–656 (2020). |
| [36] | Jinchun Rock. The diagnostic value of serum tumor markers in 30 cases of colorectal cancer [J]. Journal of Medicine, Yanbian University, 2022, 45 (04): 290-291. |
| [37] | Adileh, M., Mor, E., Assaf, D. et al. Perioperative and Oncological Outcomes of Combined Hepatectomy with Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Metastatic Colorectal Cancer. Ann Surg Oncol 28, 3320–3329 (2021). |
| [38] | Kiritani, S., Yoshimura, K., Arita, J. et al. A new rapid diagnostic system with ambient mass spectrometry and machine learning for colorectal liver metastasis. BMC Cancer 21, 262 (2021). |
| [39] | Ghorra, C., Pommier, R., Piveteau, A. et al. The diagnostic performance of a simulated "short" gadoxetic acid-enhanced MRI protocol is similar to that of a conventional protocol for the detection of colorectal liver metastases. Eur Radiol 31, 2451–2460 (2021). |
| [40] | Zhu Dexiang, Ren Li, Xu Jianmin. Guidelines for the Diagnosis and Comprehensive Treatment of Liver Metastasis of Colorectal Cancer in China (2023 Edition) [J]. Chinese Journal of General Surgery, 2023, 32 (01): 1-29. |
| [41] | Yi H, Liao ZW, Chen JJ, Shi XY, Chen GL, Wu GT, Zhou DY, Zhou GQ, Huang JY, Lian L, Yu ZY, He SB. Genome variation in colorectal cancer patient with liver metastasis measured by whole-exome sequencing. J Gastrointest Oncol. 2021 Apr; 12 (2): 507-515. PMID: 34012644; PMCID: PMC8107593. |
| [42] | Li, B., Cai, SL., Lv, ZT. et al. Self-expandable metallic stenting as a bridge to elective surgery versus emergency surgery for acute malignant right-sided colorectal obstruction. BMC Surg 20, 326 (2020). |
| [43] | Swierz MJ, Storman D, Riemsma RP, Wol_x001D_ R, Mitus JW, Pedziwiatr M, Kleijnen J, Bala MM. Transarterial (chemo) embolisation versus no intervention or placebo for liver metastases. Cochrane Database of Systematic Reviews 2020, Issue 3. Art. No.: CD009498. |
| [44] | Deng Xianlun, Feng Libo, Xu Jianwei, etc. Expression level and significance of ubiquitinated carboxyl terminal hydrolase 37 in colorectal cancer tissue [J]. Chinese Journal of Modern Medicine, 2018, 28 (30): 32-36. |
| [45] | Ma ZH, Wang YP, Zheng WH, Ma J, Bai X, Zhang Y, Wang YH, Chi D, Fu XB, Hua XD. Prognostic factors and therapeutic effects of different treatment modalities for colorectal cancer liver metastases. World J Gastrointest Oncol 2020; 12 (10): 1177-1194. |
| [46] | Hui Peng, Liu Lianxin, Liang Yingjian. Research progress on the molecular mechanism of liver metastasis in colorectal cancer [J]. Chinese Journal of General Basics and Clinical, 2019, 26 (06): 758-763. |
| [47] | Helmberger, T., Golfieri, R., Pech, M. et al. Clinical Application of Trans-Arterial Radioembolization in Hepatic Malignancies in Europe: First Results from the Prospective Multicentre Observational Study CIRSE Registry for SIR-Spheres Therapy (CIRT). Cardiovasc Intervent Radiol 44, 21–35 (2021). |
| [48] | Li Xinhui, Zuo Zhigang, Cai Xiaojun, Tang Jiying, Xiong Liuxin. The efficacy and safety analysis of SBRT combined with FOLFIRI compared with FOLFOXIRI in the treatment of liver oligostasis in colon cancer [J]. Journal of Hubei Medical College, 2020, 39 (05): 457-462+476. |
| [49] | Panboqu. Analysis of the efficacy, complications and survival rate of minimally invasive surgery in patients with colorectal cancer combined with liver metastasis [J]. Contemporary Medicine, 2020, 26 (27): 23-25. |
| [50] | Li Jiang, Hou Yu, Cai Xiaobei, Xu Chenglei, Yi Genfa. The local treatment model based on restricted segment resection to improve the prognosis analysis of liver oligostasis after colorectal cancer surgery [J]. Journal of Clinical Hepatobiliary Disease, 2020, 36 (08): 1763-1767. |
| [51] | He Yunlong, Cheng Zhuoxin. Advances in the treatment of colorectal cancer [J]. Electronic Journal of Clinical Medical Literature, 2018, 5 (11): |
| [52] | Fan Haijun, Tian Daguang, Wei Xiaoping, Wang Hua, Lin Jie, Sun Yan, Yi Xiaojia. Multidisciplinary team's diagnosis and treatment of 1 case of simultaneous liver metastasis of rectal cancer [J]. Clinical research in China, 2020, 33 (04): 542-546. |
| [53] | He Wenting. Literature Evaluation of Traditional Chinese Medicine Diges in 8, 147 Patients with Colorectal Cancer [C]//Chinese Society of Integrated Traditional Chinese and Western Medicine. Proceedings of the Fifth World Conference on Integrated Traditional Chinese and Western Medicine in 2017 (Volume 2) [Publisher unknown], 2017: 1. |
| [54] | Yu Guanyu, Wang Wei, Gong Haifeng, Sui Jinke, Zhu Xiaoming, Shen Fu, Bai Chenguang, Yang Jijin, Zhang Huojun, Li Gang, Zhou Weiping, Zhang Wei. MDT diagnosis and treatment of patients with sigmoid colon cancer with giant liver metastasis [J]. Journal of Practical Oncology, 2021, 36 (06): 483-489. |
| [55] | Li Jia, Gao Jia, Cui Chanjuan, Yu Mengyao, Zhang Hao, Cui Wei. Application value of serum type IV collagen level in liver metastasis of colorectal cancer [J]. Marker immunoassay and clinical, 2021, 28 (10): 1689-1692. |
| [56] | T. Yoh, A. Perrot, A. Beaufrère, C. Hobeika, R. Sartoris, V. Paradis, Guo Wenwen. Liver surface nodules: a new predictor of liver failure after chemotherapy in patients with colorectal cancer after chemotherapy [J]. International Journal of Medical Radiology, 2021, 44 (05): 614. |
| [57] | Zhao Zhengqiang, Chen Long, Liu Yujie, Tian Suqing. Prognostic factors after hepatectomy in patients with positive PD-L1 gene in colorectal cancer liver metastasis [J]. Tumor prevention and treatment research, 2021, 48 (08): 782-787. |
| [58] | Xiong Lifeng, Sun Hang. Clinical Observation of Baitou Weng Decoction Combined with Chemotherapy in the Treatment of Damp and Heat Conjunction Advanced Colorectal Cancer [J]. Zhejiang Journal of Traditional Chinese Medicine, 2021, 56 (07): 509. |
| [59] | Chen Gongqin, Guo Hui. A single case of a huge liver metastasis of sigmoid colon cancer [J]. Inner Mongolia Medical Journal, 2021, 53 (06): 765-766+769. |
| [60] | Wei heavy exercise, Wang Jing, Xing Xin, etc. Analysis of the diagnosis rate and clinicopathological characteristics of early colorectal cancer [J]. Journal of Gastroenterology and Hepatology, 2022, 31 (10): 1154-1159. |
| [61] | Hu Xiaoming. Application analysis of multi-slice spiral CT in the diagnosis of hepatic calcified metastases in colorectal cancer [J]. Modern Medical Imaging, 2021, 30 (03): 503-505. |
| [62] | Mali Ping. Imaging characteristics and diagnostic analysis of MSCT of hepatic calcified transgenesis in colorectal cancer [J]. Modern diagnosis and treatment, 2021, 32 (05): 780-781. |
| [63] | Deng Yao et al. Bisphenol A exposure, interaction with genetic variants and colorectal cancer via mediating oxidative stress biomarkers [J]. Environmental Pollution, 2021, 287: 117630-117630. |
| [64] | Song Qingqing, Li Changsheng, Zhang Yingli. Analysis of the relevant influencing factors of liver metastasis after radical resection of colorectal cancer [J]. Journal of Practical Cancer, 2023, 38 (01): 115-118. |
| [65] | Greger, A., Sostmann, H., Al Toki, M. et al. Synchrone solitäre Pankreasmetastase eines neu diagnostizierten Kolonkarzinoms. coloproctology 40, 211–216 (2018). |
| [66] | M. Karageorgou, D. Myoteri, T. Kotsis, G. Polymeneas, E. Bournakis, D. Dellaportas, "Solitary Colorectal Cancer Metastasis to the Pancreas", Case Reports in Surgery, vol. 2019, Article ID 4891512, 3 pages, 2019. |
| [67] | Bastian, Keck, Tilman, Rau T, Frens, Krause S, Bernhardt, Walter, Peter, Goebell J. Arndt, Hartmann, Bernd, Wullich, Diagnostic challenge of atypical colorectal metastasis to the renal pelvis [J]. Int J Colorectal Dis (2011) 26: 52–524. |
| [68] | Chu Haiyan, Xin Junyi, Yuan Qi et al. A prospective study of the associations among fine particulate matter, genetic variants, and the risk of colorectal cancer [J] Environment International, 2021, 147. |
| [69] | Li Chunhei, Yang Ooi Setthasorn Zhi, Woo Timothy et al. Addressing the quality of hospital care of colorectal cancer patients undergoing surgery: what did we learn from the national bowel cancer audit?[J] European Journal of Surgical Oncology, 2021, 47 (1). |
| [70] | Yang Yufang, Zhu Wenjing, Ye Hong. 1 case of uterine metastasis after comprehensive treatment of rectal cancer [J]. Bachu Medicine, 2019, 2, (02): 89-90+108. |
| [71] | Zhang Kun, Han Xia, Wu Xiaohan, Yang Xiaoqian, Chen Shaoshui. A case of colorectal cancer with giant ovarian metastasis reported and literature review [J]. Chinese Medical Sciences, 2022, 12 (18): 185-189. |
| [72] | Lin Yuhe, Yao Wei, Fei Qian, Wang Ying. 2 cases of ovarian metastasis of colorectal cancer are reported and reviewed in the literature [J]. Journal of China Medical University, 2022, 51 (02): 187-189. |
| [73] | Chen Yi, Zhang Ying, Wang Ying. Research status and progress of ovarian metastasis of colorectal cancer [J]. Chinese Electronic Journal of Colorectal Diseases, 2020, 9 (05): 498-501. |
| [74] | Peng Liyuan, Jiang Jingwen, Chen Hai-Ning et al. Redox-sensitive cyclophilin A elicits chemoresistance through realigning cellular oxidative status in colorectal cancer [J] Cell Reports, 2021, 37 (9). |
| [75] | Korkmaz et al. Journal of the Egyptian National Cancer Institute (2021) 33: 3. |
| [76] | Kwon, Soon Keun; Yu, Chang Sik; Lee, Shin-Wha; Kim, Jihun; Song, Inho; Lee, Jong Lyul; Kim, Chan Wook; Yoon, Yong Sik; Park, In Ja; Lim, Seok-Byung; Kim, Jin Cheon et. al. WORLD JOURNAL OF CLINICAL CASES (2020): 527-534. |
| [77] | Zou Xia; Lu Jishun; Deng Yao; Liu Qiannan; Yan Xialin; Cui Yalu; Xiao Xiao; Fang Meng; Yang Fang; Sawaki Hiromichi; Sato Takashi; Tan Binbin; Lu Xiaoyan; Feng Bo; Kuno Atsushi; Narimatsu Hisashi; Gao Chunfang; Zhang Yan ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface. [J] Oncogene, 2022. |
| [78] | Yuan Rui, Yuan Weitang. Analysis of prognostic risk factors and prognostic linemap construction in patients with bone metastasis of colon cancer [J]. Henan Medical Research, 2022, 31 (16): 2931-2936. |
| [79] | Zhang Qing, Zhang Fangyuan, Shang Yun, Zhang Cailei. CT-guided application of ~ (125) I radioactive particle implantation combined with chemotherapy on patients with bone metastasis of colorectal cancer [J]. Electronic Journal of Tumor Comprehensive Therapy, 2022, 8 (03): 98-102. |
| [80] | Xu Jianfa, Tan Zirui, Li Jie, Wang Miao, Wang Guiying. Construction and analysis of prognosis and prediction of patients with rectal cancer bone metastasis [J]. Clinical Collection, 2021, 36 (05): 446-452. |
| [81] | Ying Hong'an, Hong Weiwen, Lin Feng, Ding Ruliang, Zhang Wei. 1 case of complete clinical remission of rectal cancer bone metastasis after new adjuvant treatment [J]. Journal of Wenzhou Medical University, 2021, 51 (03): 240-243. |
| [82] | Ma Chenxi, Guan Xu, Wang Xishan. Research status and treatment of bone metastasis in colorectal cancer [J]. Chinese Electronic Journal of Colorectal Diseases, 2020, 9 (06): 605-609. |
| [83] | Zhang Shibin. Diagnostic value of multi-slice spiral CT for bone metastasis of colorectal cancer [J]. Journal of Practical Medical Imaging, 2020, 21 (04): 406-408. |
| [84] | Li, X., Hu, W., Sun, H. et al. Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a po Pulation-based study. Clin Exp Metastasis 38, 89–95 (2021). |
| [85] | Guan X, Ma Cx, Quan Jc, Zhao Zx, Chen Hp, Sun P, Wang S, Lu Z, Ma Xl, Liu Z, Jiang Z, Wang Xs. A prognostic index model to individually predict clinical outcomes for colorectal cancer with synchr Onous bone metastasis. J Cancer 2020; 11 (15): 4366-4372. |
| [86] | Park, H. S., Chun, Y. J., Kim, H. S. et al. Clinical features and KRAS mutation in colorectal cancer with bone metastasis. Sci Rep 10, 21180 (2020). |
| [87] | Bhakta J, Dewdney A. Colorectal cancer bone metastasis compressing the sagittal sinus. Br J Hosp Med. 2020. |
| [88] | Han, L., Dai, W., Mo, S. et al. Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a pop Ulation-based real-world analysis. Int J Colorectal Dis 35, 1575–1585 (2020). |
| [89] | Qin Xiaojuan; Deng Yao Carotid intramural haematoma after ultrasound-guided fine-needle aspiration biopsy. [J] Asian Journal of Surgery, 2022. |
| [90] | Alessandro Bianchi et al. Aberrant single metastasis to the elbow from primary rectal cancer: a rare presentation. Pan African Medical Journal. 2020; 36 (383). |
| [91] | Qian Haifeng; Deng Yao; Li Yahang; Mou Zhigang; Lei Weining Research on nickel-based reduced graphene oxide composite electrodeposited layer prepared by supercritical double pulse condition [J] Ferroelectrics, 2023. |
| [92] | Lei Shuzhen, Ge Yan, Tian Shuxian, etc. The metastasis of colorectal cancer to the brain or bone and its relationship to the location of the primary tumor: a population-based study. J Gastrointest Surg 24, 1833–1842 (2020). |
| [93] | Hermiö Elina; Seppä Karri; Ryynänen Heidi; Hirvonen Elli; Pylkkänen Liisa; Järvelin Jutta; Malila Nea; Pitkäniemi Janne Use of health services one year before primary colorectal cancer. [J] BMC Health Services Research, 2019. |
APA Style
Liu Chao, Linda Chiuman. (2023). Analysis of the Characteristics of Colorectal Cancer or Malignant Colorectal Tumors Transferred to Other Organs: A Population-Based Study. International Journal of Clinical Oncology and Cancer Research, 8(1), 11-19. https://doi.org/10.11648/j.ijcocr.20230801.13
ACS Style
Liu Chao; Linda Chiuman. Analysis of the Characteristics of Colorectal Cancer or Malignant Colorectal Tumors Transferred to Other Organs: A Population-Based Study. Int. J. Clin. Oncol. Cancer Res. 2023, 8(1), 11-19. doi: 10.11648/j.ijcocr.20230801.13
AMA Style
Liu Chao, Linda Chiuman. Analysis of the Characteristics of Colorectal Cancer or Malignant Colorectal Tumors Transferred to Other Organs: A Population-Based Study. Int J Clin Oncol Cancer Res. 2023;8(1):11-19. doi: 10.11648/j.ijcocr.20230801.13
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ijcocr.20230801.13,
author = {Liu Chao and Linda Chiuman},
title = {Analysis of the Characteristics of Colorectal Cancer or Malignant Colorectal Tumors Transferred to Other Organs: A Population-Based Study},
journal = {International Journal of Clinical Oncology and Cancer Research},
volume = {8},
number = {1},
pages = {11-19},
doi = {10.11648/j.ijcocr.20230801.13},
url = {https://doi.org/10.11648/j.ijcocr.20230801.13},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijcocr.20230801.13},
abstract = {Advanced colorectal cancer and malignant tumors metastasize other organs, which seriously threaten human health. Such patients have a low five-year survival rate and poor quality of life. Therefore, it is necessary to study such patients. There is still a long way to go for doctors. Our study uses retrospective research methods to statistically analyze the metastasis of colorectal cancer and other organs and tissues metastasis of colorectal malignant tumors. Let's pay full attention to such patients. Because the treatment recommended by many clinicians in the later stage is different. Some doctors recommend active treatment. Some doctors recommend giving up treatment. Therefore, this study aims to make doctors pay attention to the treatment and treatment process of advanced colorectal cancer and colorectal malignant tumors metastasis of other organs in the later stage, so as to improve the survival rate of patients and improve the quality of life of patients. Research background: At present, colorectal cancer or colorectal malignant tumors seriously endanger human health around the world. The main reason is our insufficient understanding of colorectal cancer. We don't attach importance to health education. We have insufficient preventive measures for intestinal cancer and the promotion of risk factors, and the inadequacy of early screening for intestinal cancer, so that some patients are late tumors when colorectal cancer is found. At the same time, patients with such tumors are prone to the invasion of peripheral tissues or the transfer of tumors to surrounding tissues and organs. The survival rate of patients has been greatly reduced. Objective: To improve the 5-year survival rate of patients with advanced colorectal cancer or malignant colorectal tumor and improve their quality of life. Our research on this kind of patients is meaningful. Research method: We use retrospective research. In CNKI and PubMed public database, the number of studies and cases on the transfer of colorectal cancer or colorectal malignant tumors to other organs from 2020 to 2023 were statistically retrieved, and finally analyzed. Organs include: brain, lung, liver, pancreas, kidney, uterus, ovaries and bones. Included criteria: colorectal cancer or colorectal malignant tumors, brain metastasis, lung metastasis, liver metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis, bone metastasis. Results: The most common metastasis of colorectal cancer in this study is the liver (47.2%), bone (34.9%), lung (7.5%), ovarian and vagina (6.1%), brain (4.3%). Pancreas, kidneys and uterus are relatively rare, but there are still clinical reports.},
year = {2023}
}
TY - JOUR T1 - Analysis of the Characteristics of Colorectal Cancer or Malignant Colorectal Tumors Transferred to Other Organs: A Population-Based Study AU - Liu Chao AU - Linda Chiuman Y1 - 2023/04/11 PY - 2023 N1 - https://doi.org/10.11648/j.ijcocr.20230801.13 DO - 10.11648/j.ijcocr.20230801.13 T2 - International Journal of Clinical Oncology and Cancer Research JF - International Journal of Clinical Oncology and Cancer Research JO - International Journal of Clinical Oncology and Cancer Research SP - 11 EP - 19 PB - Science Publishing Group SN - 2578-9511 UR - https://doi.org/10.11648/j.ijcocr.20230801.13 AB - Advanced colorectal cancer and malignant tumors metastasize other organs, which seriously threaten human health. Such patients have a low five-year survival rate and poor quality of life. Therefore, it is necessary to study such patients. There is still a long way to go for doctors. Our study uses retrospective research methods to statistically analyze the metastasis of colorectal cancer and other organs and tissues metastasis of colorectal malignant tumors. Let's pay full attention to such patients. Because the treatment recommended by many clinicians in the later stage is different. Some doctors recommend active treatment. Some doctors recommend giving up treatment. Therefore, this study aims to make doctors pay attention to the treatment and treatment process of advanced colorectal cancer and colorectal malignant tumors metastasis of other organs in the later stage, so as to improve the survival rate of patients and improve the quality of life of patients. Research background: At present, colorectal cancer or colorectal malignant tumors seriously endanger human health around the world. The main reason is our insufficient understanding of colorectal cancer. We don't attach importance to health education. We have insufficient preventive measures for intestinal cancer and the promotion of risk factors, and the inadequacy of early screening for intestinal cancer, so that some patients are late tumors when colorectal cancer is found. At the same time, patients with such tumors are prone to the invasion of peripheral tissues or the transfer of tumors to surrounding tissues and organs. The survival rate of patients has been greatly reduced. Objective: To improve the 5-year survival rate of patients with advanced colorectal cancer or malignant colorectal tumor and improve their quality of life. Our research on this kind of patients is meaningful. Research method: We use retrospective research. In CNKI and PubMed public database, the number of studies and cases on the transfer of colorectal cancer or colorectal malignant tumors to other organs from 2020 to 2023 were statistically retrieved, and finally analyzed. Organs include: brain, lung, liver, pancreas, kidney, uterus, ovaries and bones. Included criteria: colorectal cancer or colorectal malignant tumors, brain metastasis, lung metastasis, liver metastasis, pancreatic metastasis, kidney metastasis, uterine metastasis, ovarian metastasis, bone metastasis. Results: The most common metastasis of colorectal cancer in this study is the liver (47.2%), bone (34.9%), lung (7.5%), ovarian and vagina (6.1%), brain (4.3%). Pancreas, kidneys and uterus are relatively rare, but there are still clinical reports. VL - 8 IS - 1 ER -
Information
Email: